DoD Rare Cancers, Idea Development Award
Department of Defense
Description
The FY25 Rare Cancers Research Program Idea Development Award is designed to support early-stage, innovative research ideas that could provide significant insights and new research directions in rare cancers. Applicants are encouraged to include exploratory aims to facilitate discovery-driven research. Preliminary data with a disease-specific rationale are required, but this data doesn't necessarily have to come from the specific rare cancer type being studied. The research should aim to hav…
Summary: The fiscal year 2025 (FY25) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation.
Distinctive…
Source
Grant ID
HT942525RCRPIDA
Agency
Department of Defense
Subcategory/Subagency
Dept. of the Army -- USAMRAA
Key Dates
Solicitation Posted
May 1, 2025
Application Response Due
October 6, 2025
Eligibility
The following categories of applicants are invited to apply:
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Awards & Funding
Total Funding
$6.9M
Funding Amount
Discretionary
Links
Documents
Similar opportunities
- Exploratory/Developmental Research Grant Program (R21)
National Institutes of Health
- DOD Ovarian Cancer, Investigator-Initiated Research Award
Department of Defense
- DoD Rare Cancers, Concept Award
Department of Defense
- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
Department of Health and Human Services
- DoD Prostate Cancer, Idea Development Award
Department of Defense